The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tikhomirov A.L.

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Sarsania S.I.

Aeterna clinic

Dedy T.V.

Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies

Osetskaya E.A.

Medical holding «CM Clinic»

Clinical examples of the rational applying of the «gold standard» of hormonal therapy for endometriosis

Authors:

Tikhomirov A.L., Sarsania S.I., Dedy T.V., Osetskaya E.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2021;21(4): 99‑103

DOI: 10.17116/rosakush20212104199

Read: 4045 times

Download PDF (RU)
Contact the author
Table of contents

CLINICAL EXAMPLES OF THE RATIONAL APPLYING OF THE «GOLD STANDARD» OF HORMONAL THERAPY FOR ENDOMETRIOSIS
CLINICAL EXAMPLES OF THE RATIONAL APPLYING OF THE «GOLD STANDARD» OF HORMONAL THERAPY FOR ENDOMETRIOSIS

To cite this article:

Tikhomirov AL, Sarsania SI, Dedy TV, Osetskaya EA. Clinical examples of the rational applying of the «gold standard» of hormonal therapy for endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2021;21(4):99‑103. (In Russ.)
https://doi.org/10.17116/rosakush20212104199

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Quality of life and psychosomatic status of women of reproductive age with adenomyosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):83-89
Controversial issues of adju­vant therapy after myomectomy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):101-107
Stru­ctural and biochemical features of menstrual discharge in patients with uterine fibroids. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):85-90
Comparison of the main methods of surgical treatment of patients with colo­rectal endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):118-123
The role of systemic and local immu­nity in the pathogenesis of endo­metriosis of varying degrees of prevalence of the process: a modern view. Russian Journal of Human Reproduction. 2024;(5):6-14
Hete­rogeneity of the mole­cular phenotype with uterine fibroids. Message II. Russian Journal of Human Reproduction. 2024;(5):15-24
The role of ferroptosis in reproduction. A modern view of the problem. Russian Journal of Human Reproduction. 2024;(5):35-45
The influence of endo­metriosis on the quality of life and reproductive function of modern woman. Russian Journal of Human Reproduction. 2024;(5):101-107
Effi­ciency of using dienogest at the stage of pregravid preparation on the course of pregnancy and the outcome of childbirth in patients with endo­metriosis. Russian Journal of Human Reproduction. 2024;(5):118-125
Oxidative stress, ferroptosis, soma­tic muta­tions, antioxidant therapy, and endo­metriosis: a new perspective on the issue. Russian Journal of Human Reproduction. 2024;(6):32-44
Abstract:

The publication considers the pathogenesis validity for the use of analogues of gonadotropic releasing hormone (a-GnRH) as a basic hormone therapy for endometriosis (E). Clinical examples of the rational use of locally produced a-GnRH depot-form are given. The applying of a-GnRH provides doctor with the opportunity to personalize the therapy of patients with endometriosis taking into account the clinical situation and patients’ needs including those with a combined gynecological pathology of a proliferative hormone-dependent nature. Clinical examples of applying a-GnRH «Buserelin-depot» are given.

Keywords:

endometriosis
adenomyosis
uterine fibroids
organ-preserving treatment
and a-GnRH

Authors:

Tikhomirov A.L.

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Sarsania S.I.

Aeterna clinic

Dedy T.V.

Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies

Osetskaya E.A.

Medical holding «CM Clinic»

Received:

23.06.2021

Accepted:

02.07.2021

Close metadata

References:

  1. Miinistry of Health of the Russian Federation. Clinical recommendations. Endometriosis. 2020. (In Russ.).
  2. Borghese B, Zondervan KT, Abrao MS, Chapron C, Vaiman D. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 2017;91:2:254-264.  https://doi.org/10.1111/cge.12897
  3. Bouaziz J, Mashiach R, Cohen S, Kedem A, Baron A, Zajicek M, Feldman I, Seidman D, Soriano D. How artificial intelligence can improve our understanding of the genes associated with endometriosis: Natural Language Processing of the PubMed Database. Biomed Res Int. 2018;2018:6217812. https://doi.org/10.1155/2018/6217812
  4. Zhang Z, Ruan L, Lu M, Yao X. Analysis of key candidate genes and pathways of endometriosis pathophysiology by a genomics-bioinformatics approach. Gynecol Endocrinol. 2019;35:7:576-581.  https://doi.org/10.1080/09513590.2019.1576609
  5. Gynecology. National guide. Ed. by Savel’eva G.M., Sukhikh G.T., Serov V.N., Radzinskii V.E., Manukhin I.B. M.: GEOTAR-Media; 2017. (In Russ.).
  6. Konings G, Brentjens L, Delvoux B, Linnanen T, Cornel K, Koskimies P, Bongers M, Kruitwagen R, Xanthoulea S, Romano A. Intracrine regulation of estrogen and other sex steroid levels in endometrium and non-gynecological tissues; Pathology, Physiology, and Drug Discovery. Front Pharmacol. 2018;9:940.  https://doi.org/10.3389/fphar.2018.00940
  7. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:3:400-412. 
  8. Xholli A, FiLip G, Previtera F, Cagnacci A. Modification of endometrioma size during hormone therapy containing dienogest. Gynecol Endocrinol. 2020;36:6:545-549.  https://doi.org/10.1080/09513590.2019.1703942
  9. Maiorana A, Incandel D, Parazzini F, Alio W, Mercurio A, Giambanco L, Alio L. Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience. Arch Gynecol Obstet. 2017;296:3:429-433.  https://doi. org/10.1007/s00404-017-4442-5
  10. Sugimoto K, Nagata C, Hayashi H, Yanagida S, Okamoto A. Use of dienogest over 53 weeks for the treatment of endometriosis. Journal of Obstetrics and Gynaecology Research. 2015;41:12:1921-1926.
  11. Hirata T, Izumi G, Takamura M, Saito A, Nakazawa A, Harada M, Hirota Y. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecological Endocrinology. 2014;30:10:726-729. 
  12. Lee SR, Yi KW, Song JY, Seo SK, Lee DY, Cho SH, Kim SH. Efficacy and safety of long-term use of dienogest in women with ovarian endometrioma. Reproductive Sciences. 2017;25:3:341-346. 
  13. Agarwa S, Fraser MA, Chen I, Singh SS. Dienogest for the treatment of deep endometriosis: Case report and literature review. Journal of Obstetrics and Gynaecology Research. 2014;41:2:309-313. 
  14. Techatraisak K, Hestiantoro A, Ruey S, Banal-Silao MJ, Kim MR. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. BMC Women’s Health. 2019;19:1:68. 
  15. Strowitzki T, Faustmann T, Gerlinger C, Schumacher U, Ahlers C, Seitz C. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Womens Health. 2015;7:393-401. 
  16. Tikhomirov A.L. The main line of hormone therapy and hormonal prevention of endometriosis at the present stage of medical development. Rossiiskii vestnik akushera-ginekologa. 2020;20:3:90-93. (In Russ.). https://doi.org/10.17116/rosakush20202003190
  17. Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017;96:6:623-663.  https://doi.org/10.1111/aogs.13156
  18. Abdou AM, Ammar IMM, Alnemr AAA, Abdelrhman A. Dienogest versus leuprolide acetate for recurrent pelvic pain following laparoscopic treatment of endometriosis. The Journal of Obstetrics and Gyncology of India. 2018;68:4:306-313. 
  19. Takaesu Y, Nishi H, Kojima J, Sasaki T, Nagamitsu Y, Kato R, Isaka K. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis. Journal of Obstetrics and Gynaecology Research. 2016;42:9:1152-1158.
  20. RLS 2019, ATH Code: L02AE01.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.